Pancreatic Cancer Research

ResearcherColumbia UniversityNo recent work listed

Brent R. Stockwell

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3532-3868; OpenAlex author ID A5030207693; NIH RePORTER profile ID 6980256. Sources: OpenAlex.

Their work

Papers
1
Trials
0
Grants
3
Labs led
1
Collaborators
5
Papers, trials and grants by year

2014: 1 grant · 2015: 1 grant · 2016: 1 grant · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 1

  1. Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer. Co-author DOI 10.1126/scitranslmed.adg3049↗

Grants 3

  1. Chemical genetic profiling of engineered tumor cells R01CA097061↗
  2. Discovery of allele-selective KRAS inhibitors R21CA177591↗
  3. Comparing HTS with Fragment-Based Design for B-Raf and the Ras-Raf Interaction R01CA161061↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jingbo Li · 1 shared paper, 2023 · strength 0.18
  2. Jiao Liu · 1 shared paper, 2023 · strength 0.18
  3. Xin Chen · 1 shared paper, 2023 · strength 0.18
  4. Rui Kang · 1 shared paper, 2023 · strength 0.18
  5. Daolin Tang · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.